Schellenberg Wittmer has advised the shareholders of OPAL Associates Holding Ltd. Niederer Kraft Frey has advised Opal Supply Chain AG. The shareholders of OPAL Associates Holding...
Sale of OPAL Associates Holding Ltd. to Opal Supply Chain AG
InterAlpen Partners and Hale Capital Partners Invest USD 25 Million in Acutronic Holding AG
Schellenberg Wittmer advised InterAlpen Partners and Hale Capital Partners; Baker McKenzie advised Acutronic Group. InterAlpen Partners and Hale Capital Partners, a consortium of US investors, have...
Arsenal Capital Partners Sells ATP Adhesive Systems to Henkel
Schellenberg Wittmer and Kirkland & Ellis have advised Arsenal Capital Partners. Arsenal Capital Partners, a private equity firm specializing in industrial growth and healthcare companies, has...
Coca-Cola Beverages Africa Majority Stake Sold to Coca-Cola HBC AG
Schellenberg Wittmer and Mc Dermott Will & Schulte have advised The Coca-Cola Company and Gutsche Family Investments. Pestalozzi advises Coca-Cola HBC AG. The Coca-Cola Company and...
ATP adhesive systems AG’s Acquisition Of Neschen Coating
Schellenberg Wittmer, Simmons & Simmons and Jones Day acted as legal counsel for ATP adhesive systems AG on the deal. Baker McKenzie acted for UBS Switzerland...
HOCHDORF’s Sale Of HOCHDORF Swiss Nutrition And Restructuring Proceedings
Schellenberg Wittmer advised HOCHDORF Holding AG on the deal. Schellenberg Wittmer advised SIX Swiss Exchange-listed HOCHDORF Holding AG, a Swiss market leader in milk processing, specialising...
Santhera Pharmaceuticals’ License Agreement With Catalyst Pharmaceuticals
Schellenberg Wittmer advises Santhera on license for North America for Vamorolone. Santhera Pharmaceuticals (SIX: SANN) has signed an exclusive license and collaboration agreement for vamorolone in...
Swiss Post Solutions AG’s Acquisition of Avaloq Outline AG
Schellenberg Wittmer advised Avaloq Group on the deal. Avaloq Group announced its sale of Avaloq Outline AG, a global outsourcing provider for business process solutions and...
Kinarus’ Transaction Agreement With Perfect Holding
Schellenberg Wittmer advised Kinarus in this transaction. Kinarus, a privately owned clinical-stage biopharmaceutical company active in the development of novel treatments for patients suffering from serious viral,...
Credit Suisse’s Plan To Exit Nine Non-Core Wealth Management Markets in The SSA
Schellenberg Wittmer advised Credit Suisse on the deal. Credit Suisse announced its private banking client referral agreement with Barclays as part of the plan to exit nine...
Arsenal Capital Partners’ Acquisition of ATP Group
Schellenberg Wittmer advised Arsenal Capital Partners on the deal, in cooperation with Jones Day. Bär & Karrer advised Bregal, together with Latham & Watkins. Baker McKenzie...
Santhera Pharmaceuticals’ License Agreement With Sperogenix Therapeutics
chellenberg Wittmer advised Santhera Pharmaceuticals on the deal. Swiss Biotech Santhera has entered an exclusive licence agreement with China-based Sperogenix Therapeutics for the development of Vamorolone...